Validity of composite end points in clinical trials.
Montori VM, Permanyer-Miralda G, Ferreira-González I, Busse JW, Pacheco-Huergo V, Bryant D, Alonso J, Akl EA, Domingo-Salvany A, Mills E, Wu P, Schünemann HJ, Jaeschke R, Guyatt GH.
Montori VM, et al.
BMJ. 2005 Mar 12;330(7491):594-6. doi: 10.1136/bmj.330.7491.594.
BMJ. 2005.
PMID: 15761002
Free PMC article.
Review.